You are here: All Products  > Neurophth Closes $95 Million Series C+ Round for Gene Therapy Ophthalmology Therapies

Neurophth Closes $95 Million Series C+ Round for Gene Therapy Ophthalmology Therapies

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products